Annual Hazard Rates of Recurrence for Breast Cancer During 24 Years of Follow-Up: Results From the International Breast Cancer Study Group Trials I to V von Colleoni, Marco, Sun, Zhuoxin, Price, Karen N, Karlsson, Per, Forbes, John F, Thürlimann, Beat, Gianni, Lorenzo, Castiglione, Monica, Gelber, Richard D, Coates, Alan S, Goldhirsch, Aron

Volltext

Efficacy and safety of 12-weekly versus 4-weekly zoledronic acid for prolonged treatment of patients with bone metastases from breast cancer (ZOOM): a phase 3, open-label, randomis... von Amadori, Dino, Prof, Aglietta, Massimo, MD, Alessi, Barbara, MD, Gianni, Lorenzo, MD, Ibrahim, Toni, MD, Farina, Gabriella, MD, Gaion, Fernando, MD, Bertoldo, Francesco, MD, Santini, Daniele, MD, Rondena, Roberta, BSc, Bogani, Paola, BSc, Ripamonti, Carla I, MD

Volltext

Safety and efficacy analysis of neoadjuvant pertuzumab, trastuzumab and standard chemotherapy for HER2-positive early breast cancer: real-world data from NeoPowER study von Canino, Fabio, Barbolini, Monica, De Giorgi, Ugo, Fontana, Tommaso, Gaspari, Valeria, Gianni, Caterina, Gianni, Lorenzo, Maestri, Antonio, Minichillo, Santino, Moscetti, Luca, Mura, Antonella, Nicoletti, Stefania Vittoria Luisa, Omarini, Claudia, Pagani, Rachele, Sarti, Samanta, Toss, Angela, Zamagni, Claudio, Cuoghi Costantini, Riccardo, Caggia, Federica, Antonelli, Giuseppina, Baglio, Federica, Belluzzi, Lorenzo, Martinelli, Giulio, Natalizio, Salvatore, Ponzoni, Ornella, Dominici, Massimo, Piacentini, Federico

Volltext

Low-Dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-Negative Early Breast Cancer: International Breast Cancer Study Group Trial 22-00 von Colleoni, Marco, Gray, Kathryn P, Gelber, Shari, Láng, István, Thürlimann, Beat, Gianni, Lorenzo, Abdi, Ehtesham A, Gomez, Henry L, Linderholm, Barbro K, Puglisi, Fabio, Tondini, Carlo, Kralidis, Elena, Eniu, Alexandru, Cagossi, Katia, Rauch, Daniel, Chirgwin, Jacquie, Gelber, Richard D, Regan, Meredith M, Coates, Alan S, Price, Karen N, Viale, Giuseppe, Goldhirsch, Aron

Volltext

Factors influencing 5-year persistence to adjuvant endocrine therapy in young women with breast cancer von Pagan, Eleonora, Ruggeri, Monica, Bianco, Nadia, Bucci, Eraldo Oreste, Graffeo, Rossella, Borner, Markus, Giordano, Monica, Gianni, Lorenzo, Rabaglio, Manuela, Freschi, Andrea, Cretella, Elisabetta, Seles, Elena, Farolfi, Alberto, Simoncini, Edda, Ciccarese, Mariangela, Rauch, Daniel, Favaretto, Adolfo, Honecker, Friedemann, Berardi, Rossana, Franzetti-Pellanda, Alessandra, Gelber, Shari, Partridge, Ann H., Goldhirsch, Aron, Bagnardi, Vincenzo, Pagani, Olivia, Ribi, Karin

Volltext

Phase II study of liposomal doxorubicin, docetaxel and trastuzumab in combination with metformin as neoadjuvant therapy for HER2-positive breast cancer von Rocca, Andrea, Cortesi, Pietro, Cortesi, Laura, Gianni, Lorenzo, Matteucci, Federica, Fantini, Lorenzo, Maestri, Antonio, Giunchi, Donata Casadei, Cavanna, Luigi, Ciani, Rosa, Falcini, Fabio, Bagni, Antonella, Meldoli, Elena, Dall’Agata, Monia, Volpi, Roberta, Andreis, Daniele, Nanni, Oriana, Curcio, Annalisa, Lucchi, Leonardo, Amadori, Dino, Fedeli, Anna

Volltext

Randomized, open-label, phase II, biomarker study of immune-mediated mechanism of action of neoadjuvant subcutaneous trastuzumab in patients with locally advanced, inflammatory, or... von Pellegrino, Benedetta, Tommasi, Chiara, Serra, Olga, Gori, Stefania, Cretella, Elisabetta, Ambroggi, Massimo, Frassoldati, Antonio, Bisagni, Giancarlo, Casarini, Chiara, Bria, Emilio, Carbognin, Luisa, Fiorio, Elena, Mura, Antonella, Zamagni, Claudio, Gianni, Lorenzo, Zambelli, Alberto, Montemurro, Filippo, Tognetto, Michele, Todeschini, Renata, Missale, Gabriele, Campanini, Nicoletta, Silini, Enrico Maria, Maglietta, Giuseppe, Musolino, Antonino

Volltext

Trastuzumab Deruxtecan in HER2-Positive Metastatic Breast Cancer Patients with Brain Metastases: A DESTINY-Breast01 Subgroup Analysis von Jerusalem, Guy, Park, Yeon Hee, Yamashita, Toshinari, Hurvitz, Sara A, Modi, Shanu, Andre, Fabrice, Krop, Ian E, Gonzàlez Farré, Xavier, You, Benoit, Saura, Cristina, Kim, Sung-Bae, Osborne, Cynthia R, Murthy, Rashmi K, Gianni, Lorenzo, Takano, Toshimi, Liu, Yali, Cathcart, Jillian, Lee, Caleb, Perrin, Christophe

Volltext

Original Research Trastuzumab-lapatinib as neoadjuvant therapy for HER2-positive early breast cancer: Survival analyses of the CHER-Lob trial von Guarneri, Valentina, V. Dieci, Maria, Griguolo, Gaia, Miglietta, Federica, Girardi, Fabio, Bisagni, Giancarlo, Generali, Daniele G., Cagossi, Katia, Sarti, Samanta, Frassoldati, Antonio, Gianni, Lorenzo, Cavanna, Luigi, Pinotti, Graziella, Musolino, Antonino, Piacentini, Federico, Cinieri, Saverio, Prat, Aleix, Conte, PierFranco

Volltext

Tumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple-negative breast cancer enrolled in the IBCSG phase III randomized clinical trial 22-0... von Pruneri, Giancarlo, Gray, Kathryn P., Vingiani, Andrea, Viale, Giuseppe, Curigliano, Giuseppe, Criscitiello, Carmen, Láng, István, Ruhstaller, Thomas, Gianni, Lorenzo, Goldhirsch, Aron, Kammler, Roswitha, Price, Karen N., Cancello, Giuseppe, Munzone, Elisabetta, Gelber, Richard D., Regan, Meredith M., Colleoni, Marco

Volltext

Adjuvant Letrozole and Tamoxifen Alone or Sequentially for Postmenopausal Women With Hormone Receptor-Positive Breast Cancer: Long-Term Follow-Up of the BIG 1-98 Trial von Ruhstaller, Thomas, Giobbie-Hurder, Anita, Colleoni, Marco, Jensen, Maj-Britt, Ejlertsen, Bent, de Azambuja, Evandro, Neven, Patrick, Láng, István, Jakobsen, Erik Hugger, Gladieff, Laurence, Bonnefoi, Hervé, Harvey, Vernon J, Spazzapan, Simon, Tondini, Carlo, Del Mastro, Lucia, Veyret, Corinne, Simoncini, Edda, Gianni, Lorenzo, Rochlitz, Christoph, Kralidis, Elena, Zaman, Khalil, Jassem, Jacek, Piccart-Gebhart, Martine, Di Leo, Angelo, Gelber, Richard D, Coates, Alan S, Goldhirsch, Aron, Thürlimann, Beat, Regan, Meredith M

Volltext

Neoadjuvant therapy (NAT) in early breast cancer (EBC): Results from a prospective observational multicenter BRIDE study von Gori, Stefania, Ferretti, Gianluigi, Salvini, Piermario, Cretella, Elisabetta, Gianni, Lorenzo, Bighin, Claudia, Toss, Angela, Zamagni, Claudio, Vici, Patrizia, Angiolini, Catia, De Rossi, Costanza, Russo, Antonio, Bisagni, Giancarlo, Frassoldati, Antonio, Merlini, Laura, Cariello, Anna, Cinieri, Saverio, Valerio, Matteo, Porcu, Luca, Nicolis, Fabrizio

Volltext

Trastuzumab-lapatinib as neoadjuvant therapy for HER2-positive early breast cancer: Survival analyses of the CHER-Lob trial von Guarneri, Valentina, Dieci, Maria V., Griguolo, Gaia, Miglietta, Federica, Girardi, Fabio, Bisagni, Giancarlo, Generali, Daniele G., Cagossi, Katia, Sarti, Samanta, Frassoldati, Antonio, Gianni, Lorenzo, Cavanna, Luigi, Pinotti, Graziella, Musolino, Antonino, Piacentini, Federico, Cinieri, Saverio, Prat, Aleix, Conte, PierFranco

Volltext

HER-2 Expression and Cell Proliferation: Prognostic Markers in Patients With Node-Negative Breast Cancer von VOLPI, Annalisa, NANNI, Oriana, MONTI, Manlio, GIANNI, Lorenzo, AMADORI, Dino, PARADISO, Angelo, DE PAOLA, Franca, GRANATO, Anna Maria, MANGIA, Annita, MONTI, Franco, SCHITTULLI, Francesco, DE LENA, Mario, SCARPI, Emanuela, ROSETTI, Paola

Volltext

Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial von Colleoni, Marco, Luo, Weixiu, Hitre, Erika, Kamby, Claus, Müller, Bettina, Di Lauro, Vincenzo, Burstein, Harold, Bernhard, Jürg, Maibach, Rudolf, Rabaglio-Poretti, Manuela, Regan, Meredith M, Vandebroek, An, Berliere, Martine, Mitine, Carine, Vuylsteke, Peter, Glorieux, Philippe, Mebis, Jeroen, Coibion, Michael, Forget, Frederic, Duck, Lionel, Wyendaele, Wim, Pinotti, Graziella, Bernardo, Antonio, Biganzoli, Leo, Gennari, Alessandra, Forbes, John, Foo, Serene, Boyle, Frances, Abdi, Ehtesham, Na Teo, Lee, White, Shane, Gilbert, Linda, Dedes, Konstantin, Pagani, Olivia, Pedrazzini, Augusto, Rochlitz, Christoph, von Moos, Roger, Fehr, Mathias, Nyman, Per, Foukakis, Theodoros, Dabrosin, Charlotta, Fritis, Marcela, Letzkus, Jaime, Escobar, Paula, Cardemil, Juana Bernardita, Gomez, Henry, Schwartz, Joel, Bonichon-Lamichhane, Natalie, Borstner, Simona, Quispe, Oscar Zambrano, Vestlev, Peter Michael, Danø, Hella, Bews-Hair, Maria, Neades, Glyn, McKirdy, Mike, Fraser, Judith, Murphy, Dermot, Jackisch, Christian, Köcker-Korus, Heike, Stefek, Andrea, Just, Marianne, Bechtner, Christina, Grischke, Eva-Maria, Lorenz, Ralf, Dietz, Wolfgang, Thomalla, Jörg, Graf, Heiko, Busch, Steffi, Tesch, Hans, Krabisch, Petra, Rösel, Siegfried, Josten, Klaus-M, Gröll, Isolde, Mattner, Ute Marie, Garau, Isabel, Climent, Miguel Angel, López, Rafael, Bermejo, Begoña, Amillano, Kepa, Masuda, Norikazu, Toi, Masakazu, Aogi, Kenjiro, Sato, Nobuaki, Tokunaga, Eriko, Fujita, Takashi, Fridrik, Michael, Hackl, Claudia, Wette, Victor, Sevelda, Paul, Thiel, Irene, Tuttlies, Frank, Crown, John, Kennedy, John, McCaffrey, John, Murphy, Conleth, Coate, Linda, Keane, Maccon, O'Connor, Miriam, Duffy, Karen, Zardavas, Dimitrios

Volltext

Differential Benefit of Metronomic Chemotherapy Among Triple-Negative Breast Cancer Subtypes Treated in the IBCSG Trial 22-00 von Joaquin Garcia, Andrea, Rediti, Mattia, Venet, David, Majjaj, Samira, Kammler, Roswitha, Munzone, Elisabetta, Gianni, Lorenzo, Thürlimann, Beat, Laáng, István, Colleoni, Marco, Loi, Sherene, Viale, Giuseppe, Regan, Meredith M, Buisseret, Laurence, Rothé, Françoise, Sotiriou, Christos

Volltext

Omega-3 Fatty Acids for Aromatase Inhibitor-Induced Musculoskeletal Pain: Anything Other Than a Placebo Effect? von Gianni, Lorenzo, Arcangeli, Valentina, Tamburini, Emiliano, Tassinari, Davide

Volltext

Treatment and outcomes in breast cancer patients: a cross section study from the EUSOMA breast centre network von Aristei, Cynthia, Tomatis, Mariano, Ponti, Antonio, Marotti, Lorenza, de Viseu Botelho Cardoso Aires de Campos, Maria-Joao, Cheung, Kwok Leung, Curigliano, Giuseppe, De Vries, Jakob, Santini, Donatella, Sardanelli, Francesco, Van Dam, Peter, Rubio, Isabel Teresa, Baldissera, Antonella, Benozzi, Elisabetta, Berger, Johannes, Bortul, Marina, Bussels, Barbara, Cagossi, Katia, Caruso, Francesco, Cedolini, Carla, Corsi, Fabio, Despierre, Evelyn, Despini, Luca, Duhoux, Francois P, Esgueva, Antonio J., Ferrari, Alberta, Fogazzi, Gianluca, Fortunato, Lucio, Fougo, José Luis, Generali, Daniele, Gennari, Alessandra, Ghilli, Matteo, Gianni, Lorenzo, Grossi, Simona, Huscher, Alessandra, Kozłowski, Leszek, Larsson, Karolina, Matos, Leonor, Montemezzi, Stefania, Musolino, Antonio, Negreiros, Ida, Orye, Guy, Polato, Romano, Prové, Annemie, Romanucci, Giovanna, Rossi, Lorenzo, Staelens, Gracienne, Tazzioli, Giovanni, Trunfio, Martino, Vassilieff, Maud, Verhoeven, Didier, Veronesi, Paolo, Zamagni, Claudio

Volltext

Management of toxicities associated with targeted therapies for HR-positive metastatic breast cancer: a multidisciplinary approach is the key to success von Cazzaniga, Marina Elena, Danesi, Romano, Girmenia, Corrado, Invernizzi, Pietro, Elvevi, Alessandra, Uguccioni, Massimo

Volltext

Mutational analysis of triple-negative breast cancers within the International Breast Cancer Study Group von Fumagalli, Caterina, Láng, István, Munzone, Elisabetta, Gianni, Lorenzo, Gray, Kathryn P, Ruhstaller, Thomas, Guerini-Rocco, Elena

Volltext